LONDON - GSK plc (LSE:GSK) admitted 45,273 ordinary shares to trading on the London Stock Exchange’s Main Market on Monday, according to a press release statement.
The shares, with a nominal value of 31¼ pence each, were admitted under the company’s existing block listing for the GlaxoSmithKline plc Share Save Plan 2022. The admission covers shares issued between March 27, 2026 and May 22, 2026.
Following the admission, GSK’s total number of ordinary shares admitted to trading stands at 4,316,221,551. The newly admitted shares are fully fungible with existing ordinary shares under ISIN GB00BN7SWP63.
The notification was issued in conformity with Prospectus Regulation Rule 1.6.4R and signed by V A Whyte, Company Secretary, on Monday.
GSK is registered in England and Wales under company number 3888792, with its registered office at 79 New Oxford Street, London.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.